News

Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
An AI That Promises to ‘Solve All Diseases’ Is About to Test Its First Human Drugs
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...
Alphabet: Being Optimistic When Others Are Pessimistic
Alphabet's core search remains strong, with AI driving engagement, monetization, and enterprise growth at an attractive P/E ...
Alphabet-owned company to begin human trials for cancer drug developed using AI
The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.
OpenAI challenges Google Chrome with new AI-powered web browser
The browser is slated to launch in the coming weeks and aims to use artificial intelligence to fundamentally change how ...
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is…'
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...
2 Undervalued and Overlooked Artificial Intelligence (AI) Stocks With Long-Term Upside
Google Search continues to deliver strong results despite the emergence of generative AI challengers. Many times, these are ...
2 Artificial Intelligence (AI) Stocks That Could Help Make You a Millionaire
ASML and Alphabet are two of the few undervalued AI stocks around today. Rising demand for semiconductors should help ASML grow revenue. Alphabet is a leader in AI on both consumer and enterprise ...